MedTrace Logo

FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

NCT03718923 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-04-09

No results posted yet for this study

Summary

FOXP1, also known as Forkhead-box Protein P1, is a transcription factor protein belonging to the FOX gene family. Disruptions in the FOXP1 gene cause a phenotype characterized by global developmental delay, speech deficits, mild dysmorphic features, and traits of autism spectrum disorder. This study seeks to characterize FOXP1-related neurodevelopmental disorders using a number of genetic, medical and neuropsychological measures.

Conditions

Sponsors & Collaborators

  • The Seaver Foundation

    collaborator UNKNOWN

  • Autism Science Foundation

    collaborator OTHER

  • Research Foundation for Mental Hygiene, Inc.

    collaborator OTHER

  • Icahn School of Medicine at Mount Sinai

    lead OTHER

Principal Investigators

  • Elodie Drapeau, Ph.D. · Icahn School of Medicine at Mount Sinai

  • Paige Siper, Ph.D. · Icahn School of Medicine at Mount Sinai

  • Reymundo Lozano, M.D. · Icahn School of Medicine at Mount Sinai

  • Alexander Kolevzon, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-28
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03718923 on ClinicalTrials.gov